We consider the new method a promising alternative to other kinetic assays that require the use of auxiliary enzymes.
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Assay of amylase in urine is a rapid test that is often overlooked in the laboratory investigation of hyperamylasemia (1,2). In acute pancreatitis, urinary amylase excretion reportedly (3) increases above its reference interval before serum amylase does and remains increased longer. Also, the finding of a non-elevated urinary amylase excretion rate can provide a rapid presumptive diagnosis of macroainylasemia as the source of increased serum amylase in some patients (4, 5) . The clinical use of, and problems associated with, measurement of aniylase activity in serum and urine have been reviewed elsewhere (6) . A common deficiency of amylase assays is the lack of a normal reference interval for the urinary excretion rate of amylase as measured by the method.
Most of the methods devised for measuring amylase activity in serum or urine involve, as a first step, the action of amylase on a poly-or oligosaccharide (7) (8) (9) . For example, McCroskey et al. (10) described a method in which amylase cleaves p-nitrophenyl derivatives of penta-and hexaosides to yield smaller derivatized oligosaccharides; then, in a second reaction, glucosidase (EC 3.2.1.20) liberates p-nitrophenoxide, which is then measured spectrophotometrically.
Recently, a primary substrate has been synthesized that obviates the need for the glucosidase-catalyzed reaction: maltotriose, covalently bound to 2-chloro-4-nitrophenol (CNP). The reaction scheme with this substrate is as follows:
where G2 is maltoside,G3is maltotrioside, and G is glucose. The liberated CNP is measured by its absorbance at 405 run.
Because there is no requirement for a second reaction in this scheme, the method has been termed "Direct Amylase Test," or D.A.T. We compared the performance of the D.A.T. method with that of the Pantrak method by using both to measure amylase activity in 110 urine specimens from hospitalized patients. We also generated a reference interval for urine amylase from the results for timed urine specimens from 95 healthy volunteers. Specimens. For comparison of the two methods, we used untimed urine specimens from urines submitted to the University of Virginia Hospital Clinical Laboratories for routine or urgent ("stat") urinalysis. Approximately half of the 110 specimens were selected without conscious bias; the rest were screened for above-normal amylase activity in order to expand the distribution of data for comparison. Screened specimens were selected on the basis of either above-normal relative density (specific gravity) or a clinical history of pancreatitis. Specimens were stored at 5#{176}C until analysis (no longer than two days). Before assay, we centrifuged the specimens at 1000 x g. Amylase activity was measured concurrently by the direct and comparison methods in a single RA-1000 instrument.
Materials and Methods

Reagents
Subjects for the reference-interval study were selected from hospital employees who were without acute or chronic illness and were in apparent good health. The reference population consisted of 50 men and 45 women, with a mean age of 32 (SD 8) years (range: 21-59). Subjects were instructed to void and then collect the entire urine specimen approximately 2 h later, recording the exact time interval. All specimen collections were begun and completed between 0600 and 1800. After the volume was noted, the amylase activity was measured by the D.A.T. method and amylase excretion was expressed as U/h in order to compensate for variable degrees of hydration.
Human pancreatic and salivary amylases were purified as described earlier (11). Table 1 gives day-to-day precision data for the direct (D.A.T.) method and for the comparison method. Precision was calculated by using the first of duplicate determinations for each of the four quality-control materials. Within-run CVs, based on the duplicates, were 3.5% or less in all cases (not shown). Fisher's UriChem was deemed unsuitable as a quality-control material for urine amylase because of its instability over one or two days. The manufacturer provides no assay data for amylase activity in this product, although our results suggested that amylase activity in the freshlyprepared material was 100 to 130 U/L (by D.A.T.). Withinrim precision for the urine control was acceptable by each method (for Pantrak: CV = 3%, n = 12; for D.A.T.: CV = 5%, n = 14).
Resufts
Regression analysis of results from determination of amylass in untimed urine specimens by the direct (y) and comparison (x) methods yielded a slope of the regression line of 0.947 and ay-intercept of 4 U/L. The standard error of the estimate was 25 UIL. Amylase activities ranged from 11 to 1465 UIL, and the mean activity was 358 U/L (SD = 275 U/L) as measured by the comparison method. The mean and SD of the y-assay (direct method) were 343 and 267 U/L, respectively. Twenty-five of the urine specimens had amylase activities exceeding 500 U/L, for 15 it was >700 UIL, and for three it was >1000 U/L. To assess the relative reactivities of the D.A.T. and Pantrak reagents toward the salivary and pancreatic amylass isoenzymes, we measured the activities of purified human isoenzymes by the direct and comparison methods. The activities of the salivary isoenzyme preparation were 346 and 322 U/L as measured by the direct and comparison methods, respectively. Corresponding values for the pancreatic isoenzyme preparation were 276 and 274 U/L. Results of the reference-interval study are summarized in Figure 1 . The mean units of aniylase activity excreted per hour for the reference population was 7.2, with a standard deviation of 3.2. The central 95% tendency of the range, assuming a gaussian distribution, was 0.9 to 13.5 U/h. The central 95% of the reference data, estimated nonparametrically, was 1.6-15.2 U/h. One value (35.2 U/h) was removed before data analysis; no pathological or pharmacological cause for the high urine amylase activity in this individual was apparent. The mean (and SD) urinary amylase activity (UIL) was 165(101). Urine amylase activity (UIL) in the 95 specimens was significantly correlated with the calculated excretion rate (U/h): r = 0.58, P <iO.
The stability of urine amylase was evaluated in urine specimens from three healthy individuals and from two individuals in whom above-normal amylase activity in serum and urine resulted from acute pancreatitis and a pancreatic abscess, respectively. Urine from healthy individuals retained at least 80% (mean = 89%) of its original amylase activity during five days of storage at 5#{176}C. Urine from the two patients with pancreatic disorders retained at least 84% (mean = 87%) of original amylase activity after five days at 5 #{176}C.
Discussion
The present study indicates that the direct amylase test provides results that compare well with those obtained by use of the more familiar approach that requires a coupling (or auxiliary) enzyme. The elimination of auxiliary enzyme(s) in amylase assays and the use of a defined substrate have been recognized as desirable features for an amylase reference method (12). The direct and comparison methods were similarly precise (Table 1) and gave similar values for urinary enzyme activities. Moreover, their relative responses to purified human pancreatic and salivary amylases were essentially identical. It is not known, however, from these studies whether the new substrate in a different buffer would produce this same pattern of response to the two human isoenzymes. It is clear from the data in Table 1 that the two methods may give very different results with some control materials. Such differences in amylase activity measured in control materials by different methods have been noted before (13-15), and probably result from the biological sources of the aniylase enzyme in the quality-control materials.
The stability of amylase activity in various samples is often important. An incidental finding of this study was that the amylase activity in the quality-control materials (with the exception of UriChem) was stable at 5 #{176}C for at least 48 h, and amylase activity in several selected spot urine specimens from both healthy individuals and patients with pancreatic disorders appeared to be stable at 5#{176}C for at least five days after collection. Reportedly (16), amylase activity in serum from pancreatitic patients is unstable, whereas activity in serum from healthy individuals is stable for 22 h at various storage temperatures. The data from our small sample did not indicate any difference in the stabilities of amylase activity in urine specimens from healthy subjects or individuals with pancreatic disease.
With few exceptions, amylase activities measured in fresh urine specimens by the direct and comparison methOds agreed within a few percent, and linear regression analysis produced equivalent correlation data whether individual measurements or the means of duplicates were used in the analysis. In this study, regression analysis was based on the first of duplicate determinations. We conclude that there is no need, in routine use, to measure urinary amylase in duplicate.
Few recent reports include reference intervals for urinary amylase excretion rate, but our results compare closely with results previously obtained in our laboratory and with a reference range reported by Tietz (17) for a method that measures production of NADH in a multi-step reaction scheme. The non-gaussian distribution of reference values for urinary amylase excretion is in contrast to a previous study (18), which reported a normal (i.e., gaussian) distribution for 2-h urinary amylase activity in normal individuals. Total urinary amylase (U/L) activity was a reasonable predictor of amylase excretion rate (standard error of the estimate = 2.6 U/h) in a healthy reference population; however, a greater error in such an estimation can be expected for a patient population, whose hydration status is much more variable.
The direct method for aniylase appears to be a simple and precise alternative to other methods that require the use of auxiliary (or coupling) enzyme(s). The present studies of this method demonstrate that results for urine are comparable with those of the comparison method and provide a reference interval for the excretion rate for amylase in urine. These findings suggest that the new method will prove to be a useful aid in the differential diagnosis of hyperamylasemia and in the laboratory diagnosis of acute pancreatitis.
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